A spectrum of contributions of type 2 diabetes and related metabolic characteristics to dementia.
A spectrum of contributions of type 2 diabetes and related metabolic characteristics to dementia.
复制标题
2 型糖尿病和相关代谢特征对痴呆的一系列影响。
DOI:
10.1016/j.euroneuro.2014.11.009
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
SchnaiderBeeri,Michal
中科院分区:
文献类型:
--
作者:
Ravona-Springer,Ramit;SchnaiderBeeri,Michal
Findings from epidemiological, clinical and preclinical studies in recent years point to the role of metabolic factors in brain disease in general (De Felice and Ferreira, 2014; Gorelick et al., 2011), and particularly in Alzheimer’s disease (AD)(De Felice and Ferreira, 2014; de la Monte and Tong, 2014). Type 2 diabetes (T2D) and pre-diabetic states—such as insulin resistance (Craft et al., 2013), poor glycemic control (Ma et al., 2014; Ravona-Springer et al., 2014) in non-diabetic subjects (Enzinger et al., 2005), and obesity (Emmerzaal et al., 2014)—affect brain structure and function and are involved in the neuropathological pathways leading to neurodegeneration. In light of the borderline efficacy of currently approved medications for the treatment of AD (Tan et al., 2014), the failure of numerous clinical trials to prove efficacy of other medications developed for treatment of the disease, and the relatively good efficacy of medical (American Diabetes, 2010) and life-style (Hays et al., 2008) interventions in ameliorating or preventing other, non-brain-related complications of T2D, these findings raise the possibility that such interventions may have a beneficial effect on the brain.